Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Shares (Diluted)

Shares (Diluted) at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
19.9M+3.6%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
97.5M+21.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
69.7M+19.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
164.9M+3.9%
LQD
Liquidia CorporationLQDA
101.1M+18.7%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's shares (diluted)?
Kiniksa Pharmaceuticals International, plc (KNSA) reported shares (diluted) of 82.4M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's shares (diluted) changed year-over-year?
Kiniksa Pharmaceuticals International, plc's shares (diluted) increased by 8.2% year-over-year, from 76.1M to 82.4M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's shares (diluted)?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's shares (diluted) has grown at a 3.4% compound annual growth rate (CAGR), from 273.9M to 313.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.